Ovarian Cancer Clinical Trial
Digital Outreach Intervention for Lung Cancer Screening
Summary
mPATH-Lung (mobile Patient Technology for Health - Lung) is an innovative digital outreach program that identifies patients who qualify for lung cancer screening and helps them get screened. The study will: 1) Determine the effect of mPATH-Lung on receipt of lung cancer screening in a pragmatic randomized-controlled trial conducted with primary care patients in two large health networks, 2) Elucidate the drivers of patients' screening decisions and screening behavior; and 3) Explore implementation outcomes that will impact the sustainability and dissemination of mPATH-Lung using program data, surveys, and interviews.
This project will determine how mPATH-Lung affects patients' screening decisions and their completion of screening.
Full Description
Primary Objective: Determine the effectiveness of mPATH-Lung on receipt of LCS in a randomized pragmatic clinical trial of 1318 patients recruited from two large health networks, Wake Forest Baptist Health and the University of North Carolina at Chapel Hill.
Secondary Objectives:
Elucidate the drivers of patients' decisions to receive or forgo LCS through a values clarification exercise embedded within mPATH-Lung and supplemental semi-structured interviews of at least 50 patients.
Assess several critical implementation outcomes (reach, acceptability, and appropriateness) to inform the sustainability and scalability of mPATH-Lung across diverse primary care settings
Eligibility Criteria
Inclusion Criteria:
Meet the Medicare criteria for lung cancer screening, as updated in February 2022:
Age 50 - 77 years
Smoked at least 20 pack years
Current smoker or quit smoking within the past 15 years
Be scheduled to see a primary care provider within the health network in the next 3-4 weeks
Have a patient portal account or cellphone number listed in the electronic health record
Exclusion Criteria:
Patients flagged as needing a language interpreter in the electronic health record (electronic messages and intervention is delivered in English only).
Those for whom lung cancer screening would be inappropriate:
Prior history of lung cancer
Chest CT within the last 12 months
Those with medical conditions predicting shorter life expectancy
Patients whose home address is not within the state of North Carolina. (Due to telehealth guidelines)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 2 Locations for this study
Chapel Hill North Carolina, 27599, United States
Winston-Salem North Carolina, 27101, United States
How clear is this clinincal trial information?